Management of Cancer Therapy-Induced Oral Mucositis Using Photobiomodulation Therapy: An Overview of Systematic Reviews

Photobiomodul Photomed Laser Surg. 2023 Oct;41(10):513-538. doi: 10.1089/photob.2023.0091. Epub 2023 Oct 3.

Abstract

Objective: To systematically summarize the evidence for photobiomodulation therapy (PBMT) in the prevention and treatment of oral mucositis (OM) in patients undergoing cancer treatment. An electronic search was conducted in 8 databases and grey literature. Background: PBMT is recommended for the management of OM resulting from cancer treatment, with several systematic reviews (SRs) being published in recent years on this topic. Methods: Only SRs with outcomes from clinical trials were included, with no language or year restriction. The AMSTAR 2 tool was used to assess the methodological quality of the SRs. Results: Five thousand eight hundred fifty-six references were found, and 16 were selected for this review. OM prevention and treatment were favorable for PBMT in most studies, with a significant reduction in OM severity. Most studies obtained moderate confidence. Conclusions: PBMT represents an effective strategy in the management of OM, and this evidence is supported by studies with acceptable methodological quality.

Keywords: cancer therapy; light therapy; low-level light therapy; oral mucositis; photobiomodulation; stomatitis.

Publication types

  • Review

MeSH terms

  • Humans
  • Low-Level Light Therapy* / methods
  • Neoplasms* / radiotherapy
  • Stomatitis* / etiology
  • Stomatitis* / radiotherapy
  • Systematic Reviews as Topic